Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Thao Ho Le"'
Autor:
Thach Tran, Thao Ho-Le, Dana Bliuc, Bo Abrahamsen, Louise Hansen, Peter Vestergaard, Jacqueline R Center, Tuan V Nguyen
Publikováno v:
eLife, Vol 12 (2023)
Background: Fragility fracture is associated with an increased risk of mortality, but mortality is not part of doctor-patient communication. Here, we introduce a new concept called ‘Skeletal Age’ as the age of an individual’s skeleton resulting
Externí odkaz:
https://doaj.org/article/e81d03e866b445c5b6b4d60f4643b5a2
Autor:
Thach Tran, Dana Bliuc, Thao Ho-Le, Bo Abrahamsen, Joop P. van den Bergh, Weiwen Chen, John A. Eisman, Piet Geusens, Louise Hansen, Peter Vestergaard, Tuan V. Nguyen, Robert D. Blank, Jacqueline R. Center
Publikováno v:
Tran, T, Bliuc, D, Ho-Le, T, Abrahamsen, B, van den Bergh, J P, Chen, W, Eisman, J A, Geusens, P, Hansen, L, Vestergaard, P, Nguyen, T V, Blank, R D & Center, J R 2022, ' Association of Multimorbidity and Excess Mortality After Fractures Among Danish Adults ', JAMA Network Open, vol. 5, no. 10, pp. E2235856 . https://doi.org/10.1001/jamanetworkopen.2022.35856
Jama network open, 5(10):e2235856. American Medical Association
Jama network open, 5(10):e2235856. American Medical Association
ImportanceLimited knowledge about interactions among health disorders impedes optimal patient care. Because comorbidities are common among patients 50 years and older with fractures, these fractures provide a useful setting for studying interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::561b36f8034ab4feb28b3aabf7d6f446
https://doi.org/10.1001/jamanetworkopen.2022.35856
https://doi.org/10.1001/jamanetworkopen.2022.35856
Autor:
Tran, Thach, Thao Ho-Le, Bliuc, Dana, Abrahamsen, Bo, Hansen, Louise, Vestergaard, Peter, Center, Jacqueline R., Nguyen, Tuan V.
Publikováno v:
eLife; 5/16/2023, p1-17, 17p
Autor:
Neal D. Shore, Christopher Michael Pieczonka, R. Jonathan Henderson, James L. Bailen, Daniel R. Saltzstein, Raoul S. Concepcion, David Gillatt, Daniel W. Chan, Douglas Campbell, Yanling Lu, Thao Ho Le, Niantao Deng, Bradley Walsh
Publikováno v:
Journal of Clinical Oncology. 40:229-229
229 Background: Clinicians want a more accurate diagnostic test to identify patients for prostate biopsy. We have previously described the development of a Luminex based test for aggressive prostate cancer (MiCheck). To facilitate widespread deployme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::415377445881303a15909ece5a249d48
https://doi.org/10.1200/jco.2022.40.6_suppl.229
https://doi.org/10.1200/jco.2022.40.6_suppl.229
Autor:
Sandra Wissmueller, Neal D. Shore, Daniel Saltzstein, Robert Borotkanics, Julie J. Ruterbusch, Thomas A. Paivanas, Raoul S. Concepcion, Christopher Michael Pieczonka, Jennifer L. Beebe-Dimmer, Arletta van Breda, Thao Ho Le, Philip Prah, Douglas Campbell, R. Jonathan Henderson, Bradley J. Walsh, Rachel A. Levin, James Bailen
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 38:683.e1-683.e10
Background Increasing numbers of patients are presenting with aggressive prostate cancer (CaP); therefore, there exists a need to optimally identify these patients pre-biopsy. Objectives To compare the accuracy of total prostate specific antigen (PSA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cabdf1f496d26e16034b5b81576b4aae
https://doi.org/10.1016/j.urolonc.2020.03.011
https://doi.org/10.1016/j.urolonc.2020.03.011
Autor:
Bradley J. Walsh, James Bailen, Rachel A. Levin, Sandra Wissmueller, Daniel W. Chan, Daniel Saltzstein, Raoul S. Concepcion, David Gillatt, Christopher Michael Pieczonka, Julie J. Ruterbusch, Jennifer L. Beebe-Dimmer, Douglas Campbell, Thao Ho Le, Neal D. Shore, R. Jonathan Henderson
Publikováno v:
Urologic Oncology: Seminars and Original Investigations. 38:683.e11-683.e18
Background A clinical need exists for a biomarker test to accurately delineate aggressive prostate cancer (AgCaP), and thus better assist clinicians and patients decision-making on whether to proceed to prostate biopsy. Objectives To develop a blood
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c18f0998e15ce945666bc2c66bab024
https://doi.org/10.1016/j.urolonc.2020.03.010
https://doi.org/10.1016/j.urolonc.2020.03.010